Kallyope

Kallyope

Kallyope

Kallyope is a platform biotechnology company dedicated to unlocking the therapeutic and nutritional product potential of the gutbrain axis.
Type
B2b
Founded
2015
Raised
$199M
Follow us
Alexa global traffic share
25 Mar 2020
$112,000,000
Venture capital (Series C)

Kallyope Raises $112M in Series C Financing

FinSMEs
+1
05 Dec 2018
$21,000,000
Venture capital (Series B)

Kallyope Raises $21M Expansion of Series B Financing

FinSMEs
+1
22 Feb 2018
$66,000,000
Venture capital (Series B)

Kallyope scores $66 mln Series B

PE HUB
+1